Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Evolution in Practice Patterns and Differences Among Experts and Community Healthcare Providers in the Treatment of Patients with Chronic Lymphocytic Leukemia

Bing-E Xu, PhD, Kristen M Rosenthal, PhD, Krista Marcello, BA, Farrukh T. Awan, MD, Steven Coutre, MD, Nicole Lamanna, MD, Jeff P. Sharman, MD, Timothy A Quill, PhD, Kevin L Obholz, PhD, Andrew D. Zelenetz, MD PhD

Blood (2019) 134 (Supplement_1): 4724.

https://doi.org/10.1182/blood-2019-129266

Published: 2019

Journal Articles

Consensus and Divergence in Practice Patterns Among Experts and Community Healthcare Providers for the Treatment of Patients with Mantle Cell Lymphoma

Kristen M Rosenthal, PhD, Stephen M Ansell, MD PhD, John P. Leonard, MD, Julie M Vose, MDMBA, Michael L. Wang, MD, Timothy A Quill, PhD, Kevin L Obholz, PhD, Christopher R. Flowers, MD MS

Blood (2019) 134 (Supplement_1): 410.

https://doi.org/10.1182/blood-2019-124519

Published: 2019

Journal Articles

Analysis of an Online Treatment Decision Tool Reveals Variances in Practice between Experts and Oncology Healthcare Providers for Newly Diagnosed Follicular Lymphoma

Rachael M Andrie, John M Burke, MD, Christopher R. Flowers, MD MS, Nathan H Fowler, MD, Jeff P. Sharman, MD, Timothy A Quill, PhD, Kevin L Obholz, PhD, Ian W. Flinn, MD PhD

Blood (2019) 134 (Supplement_1): 414.

https://doi.org/10.1182/blood-2019-128988

Published: 2019

Journal Articles

Evolving Areas of Consensus and Disagreement Among Experts in Treatment of Patients with Multiple Myeloma (MM)

Kristen M Rosenthal, PhD, Irene M. Ghobrial, MD, Carol Ann Huff, MD, Sagar Lonial, MD, Noopur Raje, MD, Kevin L Obholz, PhD, Shaji K. Kumar, MD

Blood (2018) 132 (Supplement 1): 5664.

https://doi.org/10.1182/blood-2018-99-118941

Published: 2018

Journal Articles

Evolving Treatment Patterns of Healthcare Providers (HCPs) and Multiple Myeloma (MM) Experts from 2013-2017: Analysis of an Annually Updated Online Treatment Decision Tool

Kristen M Rosenthal, PhD, Carol Ann Huff, MD, Shaji K Kumar, MD, Suzanne Lentzsch, MD PhD, Sagar Lonial, MD, Kevin L Obholz, PhD, Terrence F. Fagan, Timothy A Quill, PhD, Kenneth C Anderson, MD

Blood (2017) 130 (Supplement 1): 3393.

https://doi.org/10.1182/blood.V130.Suppl_1.3393.3393

Published: 2017

Journal Articles

Analysis of Healthcare Provider Practice Patterns from Individual Patient Cases Entered into an Online Treatment Decision Tool for Chronic Lymphocytic Leukemia (CLL)

Kristen M Rosenthal, PhD, Farrukh T. Awan, MD MS, Steven Coutre, MD, Jeffrey A. Jones, MD MPH, MBA, Jeffrey P. Sharman, MD, Kevin L Obholz, PhD, Andrew D. Zelenetz, MD PhD

Blood (2017) 130 (Supplement 1): 5614.

https://doi.org/10.1182/blood.V130.Suppl_1.5614.5614

Published: 2017

Journal Articles

Variance between Experts and Oncology Healthcare Providers in Managing Polycythemia Vera and Myelofibrosis: Analysis of an Online Treatment Decision Support Tool

Ryan P Topping, PhD, Michael W. Deininger, MD PhD, John Mascarenhas, MD, Ruben A Mesa, MD, Brady Lee Stein, MD, Kevin L Obholz, PhD, Jason J Everly, PharmD, Srdan Verstovsek, MD PhD

Blood (2017) 130 (Supplement 1): 2106.

https://doi.org/10.1182/blood.V130.Suppl_1.2106.2106

Published: 2017

Journal Articles

Analysis of an Online Decision Support Tool for Chronic Lymphocytic Leukemia: Disparities in Treatment Selection Between Experts and Community Practitioners

Kristen M Rosenthal, PhD, Farrukh T. Awan, Jacqueline C. Barrientos, MD, Steven E. Coutre, MD, Kevin L Obholz, PhD, Andrew D. Zelenetz, MD PhD

Blood (2016) 128 (22): 5958.

https://doi.org/10.1182/blood.V128.22.5958.5958

Published: 2016

Journal Articles

Using Continuing Medical Education to Promote Shared Decision-Making in Patients Diagnosed with Multiple Myeloma

Joseph D. Tariman, PhD ANP-BC, Krista Vahey-Marcello, BA, Carol Ann Huff, MD, Shaji Kumar, MD, Angelique Vinther, BA, Andrew D. Bowser, ELS, CHCP, Timothy A Quill, PhD, Kevin L Obholz, PhD

Blood (2016) 128 (22): 2388.

https://doi.org/10.1182/blood.V128.22.2388.2388

Published: 2016

Journal Articles

Areas of Consensus and Differences Among a Panel of Experts on the Optimal Use of Newly Approved Agents to Treat Multiple Myeloma (MM): Results from an Annually Updated Online Decision Support Tool

Timothy A Quill, PhD, Kristen M Rosenthal, PhD, Shaji Kumar, MD, Suzanne Lentzsch, MD PhD, Sagar Lonial, MD FACP, G. David Roodman, MD PhD, Kevin L Obholz, PhD, Kenneth C. Anderson, MD

Blood (2016) 128 (22): 2379.

https://doi.org/10.1182/blood.V128.22.2379.2379

Published: 2016

Journal Articles

Clinical Impact of Internet-Based Tools to Help Guide Therapeutic Decisions for Mantle Cell Lymphoma (MCL)

Kristen M Rosenthal, PhD, Christopher R. Flowers, MD, Andre Goy, MD, John P. Leonard, MD, Julie M. Vose, MD, Erik D. Brady, PhD CHCP, Jim Mortimer, Kevin L Obholz, PhD, James O. Armitage, MD

Blood (2015) 126 (23): 4527.

https://doi.org/10.1182/blood.V126.23.4527.4527

Published: 2015

Journal Articles

Changes in Expert Recommendations and Global Practice Patterns from 2012-2015: Results from an Annually Updated Online Decision Aid for Multiple Myeloma (MM)

Timothy A Quill, PhD, Shaji K Kumar, MD, Suzanne Lentzsch, Sagar Lonial, MD, G. David Roodman, MD PhD, Erik D. Brady, PhD CHCP, Jim Mortimer, Kevin L Obholz, PhD, Kenneth C Anderson, MD

Blood (2015) 126 (23): 2105.

https://doi.org/10.1182/blood.V126.23.2105.2105

Published: 2015

Journal Articles

Clinical Impact of an Internet-Based Tool to Provide Expert Guidance for Multiple Myeloma (MM) from 2012 to 2014

Davecia R Cameron, MS, Sagar Lonial, MD, Amitabha Mazumder, MD, Jim Mortimer, Andrew D Bowser, ELS, CCMEP, Kevin L. Obholz, PhD, Kenneth C. Anderson, MD

Blood (2014) 124 (21): 1298.

https://doi.org/10.1182/blood.V124.21.1298.1298

Published: 2014

Journal Articles

Practice Gaps and Barriers To Optimal Care Among Hematologists and Medical Oncologists Treating Patients With Chronic Myeloid Leukemia (CML), Acute Lymphoblastic Leukemia (ALL), and B-Cell Lymphomas In The United States: Results Of a Two-Phase Qualitative/Quantitative Study

Kevin L. Obholz, PhD, Patrice Lazure, MSc, Andrew Bowser, ELS, CCMEP, Sophie Péloquin, MMedSc, Sean M. Hayes, PsyD, Jim Mortimer, Eric D. Peterson, EdM, FACEHP, B. Douglas Smith, MD

Blood (2013) 122 (21): 774.

https://doi.org/10.1182/blood.V122.21.774.774

Published: 2013

Journal Articles

Clinical Impact of an Internet-Based Tool to Help Guide Therapeutic Changes While Monitoring Patients with Chronic Myeloid Leukemia Receiving First-Line Tyrosine Kinase Inhibitor Therapy

Kevin L. Obholz, PhD, Daniel J. DeAngelo, MD, PhD, Michael J. Mauro, MD, Neil Shah, MD, PhD, B. Douglas Smith, MD, Andrew Bowser, ELS, CCMEP, Eric D. Peterson, EdM, FACEHP, Jerald P. Radich, MD

Blood (2012) 120 (21): 4279.

https://doi.org/10.1182/blood.V120.21.4279.4279

Published: 2012

NARROW

Evolution in Practice Patterns and Differences Among Experts and Community Healthcare Providers in the Treatment of Patients with Chronic Lymphocytic Leukemia

Consensus and Divergence in Practice Patterns Among Experts and Community Healthcare Providers for the Treatment of Patients with Mantle Cell Lymphoma

Analysis of an Online Treatment Decision Tool Reveals Variances in Practice between Experts and Oncology Healthcare Providers for Newly Diagnosed Follicular Lymphoma

Evolving Areas of Consensus and Disagreement Among Experts in Treatment of Patients with Multiple Myeloma (MM)

Evolving Treatment Patterns of Healthcare Providers (HCPs) and Multiple Myeloma (MM) Experts from 2013-2017: Analysis of an Annually Updated Online Treatment Decision Tool

Analysis of Healthcare Provider Practice Patterns from Individual Patient Cases Entered into an Online Treatment Decision Tool for Chronic Lymphocytic Leukemia (CLL)

Variance between Experts and Oncology Healthcare Providers in Managing Polycythemia Vera and Myelofibrosis: Analysis of an Online Treatment Decision Support Tool

Analysis of an Online Decision Support Tool for Chronic Lymphocytic Leukemia: Disparities in Treatment Selection Between Experts and Community Practitioners

Using Continuing Medical Education to Promote Shared Decision-Making in Patients Diagnosed with Multiple Myeloma

Areas of Consensus and Differences Among a Panel of Experts on the Optimal Use of Newly Approved Agents to Treat Multiple Myeloma (MM): Results from an Annually Updated Online Decision Support Tool

Clinical Impact of Internet-Based Tools to Help Guide Therapeutic Decisions for Mantle Cell Lymphoma (MCL)

Changes in Expert Recommendations and Global Practice Patterns from 2012-2015: Results from an Annually Updated Online Decision Aid for Multiple Myeloma (MM)

Clinical Impact of an Internet-Based Tool to Provide Expert Guidance for Multiple Myeloma (MM) from 2012 to 2014

Practice Gaps and Barriers To Optimal Care Among Hematologists and Medical Oncologists Treating Patients With Chronic Myeloid Leukemia (CML), Acute Lymphoblastic Leukemia (ALL), and B-Cell Lymphomas In The United States: Results Of a Two-Phase Qualitative/Quantitative Study

Clinical Impact of an Internet-Based Tool to Help Guide Therapeutic Changes While Monitoring Patients with Chronic Myeloid Leukemia Receiving First-Line Tyrosine Kinase Inhibitor Therapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only